Researchers continue to excited about the medication , a groundbreaking dual agonist showing remarkable data in initial trials for weight loss . It functions by impacting both systems: GLP-1 and GIP, which , when engaged , help control appetite and enhance calorie burn. Initial observations indicate noteworthy body reduction and potential advantage